Announcing a new article publication for Cardiovascular Innovations and Applications journal. Transcatheter aortic valve replacement (TAVR) is currently a widely used option for patients with severe symptomatic aortic stenosis with high to low surgical risk.
Clinical Trial Payments: Optimizing the Path Forward for Site Payments
Jim DiCesare, Sr. Director, Study Operations, IQVIA Clinical Trial Payments Escalating competition for clinical trial sites, in tandem with other industry-wide challenges such as changing